1. Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma
   Jiadai Xu et al, 2020, Frontiers in Immunology CrossRef
2. Complement
   Juan Carlos Varela et al, 2015, Hematology/Oncology Clinics of North America CrossRef
3. Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas
   Ting‐Tsung Chang et al, 2019, The Journal of Pathology: Clinical Research CrossRef
4. The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients
   Emelie Englund et al, 2015, BMC Cancer CrossRef
5. Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer
   Sonia I. Vlaicu et al, 2013, Immunologic Research CrossRef
6. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
   Antonella Sistigu et al, 2017, Cytokine & Growth Factor Reviews CrossRef
7. The Overlapping Roles of Antimicrobial Peptides and Complement in Recruitment and Activation of Tumor-Associated Inflammatory Cells
   Izzat A. M. Al-Rayahi et al, 2015, Frontiers in Immunology CrossRef
8. Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence
   Marcin Okroj et al, 2015, Cancer Immunology, Immunotherapy CrossRef
9. Tumour cell conditioned medium reveals greater M2 skewing of macrophages in the absence of properdin
   Izzat A.M. Al‐Rayahi et al, 2017, Immunity, Inflammation and Disease CrossRef
10. Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
    Silvio Bandini et al, 2013, OncoImmunology CrossRef
11. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
    Roberta Bulla et al, 2016, Nature Communications CrossRef
12. Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
    Izzat A. M. Al-Rayahi et al, 2021, Medicina CrossRef
13. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin‐1
    George S. Karagiannis et al, 2013, Molecular Oncology CrossRef
14. The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis
    Silvio Bandini et al, 2016, OncoImmunology CrossRef
15. Immunoglobulin G expression and its colocalization with complement proteins in papillary thyroid cancer
    Yamei Qiu et al, 2012, Modern Pathology CrossRef
16. Nanoparticle personalized biomolecular corona: implications of pre-existing conditions for immunomodulation and cancer
    Jacob Shaw et al, 2022, Biomaterials Science CrossRef